Understanding bone metastasis using photon-counting computed tomography

Verifying photon-counting computed tomography abilities to characterize and localize bone metastasis - PCD-CT trial for bone metastasis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057147

Enrollment

Registered

2025-02-27

Start date

2025-02-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone metastasis

Interventions

Scanning metastatic lesions with photon-counting CT Pre-treatment, one month and three months after radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with bone metastasis who undergo radiotherapy at our facility (Public Central Hospital of Matto Ishikawa).

Exclusion criteria

Exclusion criteria: Patients who refuse to participate this trial. We make sure that the burdens and the risks are well explained to the patients.

Design outcomes

Primary

Measure	Time frame
Signal intensities of tumor metastasis and normal tissues in the bone-marrow mode Assessment; pre-treatment, one month and three months after radiotherapy	—

Secondary

Measure	Time frame
Tumor spread on plain CT images	—

Countries

Japan

Contacts

Public ContactMasahiro Yamazaki

Central Hospital of Matto Ishikawa Department of Radiology

info@mattohp.jp076-275-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026